The Smurfit WestRock HORIZON facility is a focused, state-of-the-art clinical packaging plant placed near Dublin Airport. With a capital spending of around €40 million, this 170-person line is the first facility in the world planned fully for structured drug packaging, pharmaceutical medication obedience, and clinical trials. The HORIZON site operates under a severe pharmaceutical production ecology to confirm maximum patient focus and safety.
Smurfit Westrock has established the first-of-its-kind devotion and clinical packaging service, highlighting Ireland’s responsibility at the forefront of worldwide healthcare.
Above €40 million was spent on the brand-new site, which will offer packaging options for clinical trials and structured pharma packaging. The services are designed, and their functional procedures show those of a pharmaceutical production situation, with patients converging at the core.
Packaging has an important role in the accomplishment of clinical healthcare testing. Smurfit Westrock offers an industry-leading choice of experimental trial packaging options planned to enhance patient obedience and offer improved information.
The "HORIZON" facility, driven by Smurfit Westrock, exhibits a planned milestone in pharmaceutical packaging. As the world's first service devoted fully to patient medication and clinical trials obedience, its planned consequence lies in scrambling up smart packaging, confirming worldwide regulatory compliance, and meeting the exclusive demands of modified medicine. It offers patient-centric plans such as smart packaging and blister configurations that help patients with dense dosing plans. It utilizes progressive tracking approaches that incorporate effortlessly with serialization and worldwide track-and-trace policy. With the growth of specialized personalized therapies and biologics, packaging requests have changed from huge production runs to smaller, extremely customized groups.
The Smurfit Westrock HORIZON facility in Dublin, Ireland, is a €40m specialized clinical packaging site operated by the Smurfit Westrock Adherence & Clinicals (SWA&C) division. It is one of the world’s first packaging facilities designed exclusively for pharmaceutical patient medication adherence, regulated pharma packaging, and clinical trials. The crate seeks to solve major industry pain points by maintaining the full internal volume for goods, low weights, long service life, and high-performing temperature control while also adding space efficiency and modular repairability.
Smurfit Westrock is proud to be among a few providers of complete Bag-in-Box® and Pouch-Up® packaging systems. From films & accessories to bags, boxes, and taps, right up to filling lines, our complete solution gives you the advantage of full expertise throughout the process of packing liquids and semi-liquids. The company is delighted to be associated with a few manufacturers of full Pouch-Up® and Bag-in-Box® packaging structures. From accessories and films to bags, boxes and taps, right fit for filling lines, the full solution offers the advantage of complete proficiency during the procedure of packing semi-liquids and liquids.
Smurfit Westrock has formally initiated a €40 million obedience and clinical packaging service in Dublin, marking a considerable step in Ireland’s function as a universal center for healthcare advancement. The new site will offer specialised packaging options for clinical testing and structured pharmaceutical goods, mixing cutting-edge planning with functional developments associated with pharmaceutical production standards.
The service is planned to fulfil the strict needs of clinical and structured packaging, where patient security, compliance, and integrity are important. Its functional plans mirror pharmaceutical manufacturing ecology, confirming reliability, traceability, and consistency in each product offered. This site positions the company to establish pharmaceutical developers with effective, scalable, and patient-attentive options, from pre-phase trials to commercial positioning.
Cere™Pak is a pioneering patient obedience packaging option that presents a tiny, suppressed printed and microprocessor, conductive inks that note the date, time and place of each pill isolated from the platform. Cerepak® facilitates the elimination of each tablet.
Smurfit WestRock focuses on patient non-adherence by planning incorporated, cooperative, and digitally facilitated pharmaceutical packaging. Their options change packaging from a simple vessel to an operational clinical apparatus that enhances health results, decreases waste, and supports researchers in differentiating true drug effectiveness from patient non-adherence.
Smurfit Westrock incorporates digitalization, robotics, and AI to rationalize packaging products, optimizing entirety from mandrel case-founding and RFID labelling to end-of-line palletizing. These approaches improve throughput, minimize guide labor, moderate dimensional weight for transporting, and confirm circularity over paper-based and sustainable substrata. The company manufactures tools like wrap-around tray formers, situation packers, and developed mandrel-forming case formers that decrease resource skew and enhance durability.
Smurfit WestRock offers extremely safe, digitally incorporated packaging options customized for severely regulated sectors such as tobacco, pharmaceuticals, and clinical trials. Their expertise comprises progressive serialization, aligned defect assessment, and supervisory-compliant essential designs planned to fulfil worldwide sustainability and supply chain guidelines. Their packaging organizations observe to severe industry standards, incorporating cGMP, multilingual leaflet and insertion needs, child-barrier ideals, and localized authorities for traceability. They distribute custom databank invention and end-to-end safety options that are important for clinical troubles and highly structured product releases.
Smurfit Westrock offers data-influenced, sustainable packaging pattern facilities planned to rationalize supply chains, optimize trade management, and minimize ecological influence. It portrays core sustainability goals, expense parameters, & factory robotics limitations. The company is using internal software instruments to replicate the package performance against actual-world sales competitors. Exclusive R&D structure committed to manufacture out one-time-utilization of plastics via enhanced-strength paperboard alternatives.
Smurfit Westrock’s practice centres and consumer partnership model bring together supply chain experts, brands, and creators in immersive, rational working environments to co-generate sustainable, end-to-end packaging options. The model rushes product growth via an organised, data-influenced methodology to packaging invention. This is a constructed co-formation structure that often utilizes a 5-step simulated plan sprint that selects a packaging construct from an opening proposal to a pattern and a convincing organizational choice.
Smurfit WestRock’s global healthcare packaging network incorporates a huge footprint of around 50 converting services worldwide. It offers OTC companies, pharmaceutical, and medical device companies, with enhanced-capacity, domestic manufacturing to help supply chain security and speed. This shape confirms controlling compliance and patient security while expanding sustainability throughout distribution. The system standardizes manufacturing across its locations for custom packaging options, comprising Injectapak, DosePak, and Cerepak. The worldwide footprint offers centralized print strategies for stable Healthcare Labels and Healthcare Leaflets & Booklets, ensuring patients and suppliers receive transparent and standardized direction.
Smurfit Kappa and WestRock, Smurfit WestRock has surfaced as the world's biggest listed worldwide packaging collaborator by profits. Its competitive placement against guiding clinical packaging suppliers is termed by massive vertical incorporation, huge worldwide reach, and a robust emphasis on fibre-based sustainability. The freshly shaped Smurfit WestRock meets a competitive condition where opponents are also emphasising recyclable and sustainable fiber-based packaging. The industry’s plan includes leveraging its extended worldwide presence and boosted manufacturing expertise to establish its rank as an advisor in this progressing industry. The major understanding of its significant competitors and distinguishing factors is important for its enduring success.
Smurfit WestRock establishes pharmaceutical packaging strategies via its Better Planet Packaging programme, restoring plastics with renewable paper fibers. Their options decrease carbon footprints via feature paper-based pattern, circular supply chains, optimize waste decrease, and child-barrier and senior-friendly medicine packaging. It utilises renewable paper fibers in place of plastic enclosures to ensure bottles and vials are transported. Continuous incorporation of packaging positions, showing print-on-demand control located immediately within client services.
Smurfit Westrock is insistently capitalizing on healthcare and clinical packaging via patient-centric strategies, sustainable fiber-based production, and digital supply chain incorporation. The major development vectors center on dropping waste, enhancing trial obedience, and confirming compliance via worldwide scalability. With the increasing universal induce to phase out one-time utilization of plastics, there is a huge market potential for the company’s renewable paper-based first-aid and healthcare packaging.
Healthcare packaging has an important role in defending products, accompanying compliance and offering transparent data to providers and patients. The paper-based healthcare packaging choices are manufactured to fulfil the company’s enhanced standards for efficiency, safety, and usability without disturbing sustainability. From labels to leaflets to safeguard packaging systems, an integrated advance supports healthcare companies to offer certainty with each dose and tools. With complex growth and commercialization procedures, the medicine industry needs packaging that reports the exclusive requirements of every stage of the product life cycle. From prescription drug packaging that enhances obedience and patient capability to end-to-end safety options, the company utilize innovative technology and bold invention to resolve significant industry trials.
Smurfit Westrock’s HORIZON is a developed packaging platform offered to pharmaceutical medicine obedience, structured clinical trials and medical packaging. Supported by a $43 million investment in a near-Dublin Airport capability near Dublin Airport and established by universal sites in China and the US, it influences accuracy healthcare over joined digital tracking, patient-focused paper-based packaging, and cold chain testing.
For Costco, the variation to paper-based EnduraGrip® staples was so effective that the team found a chance to take the option. While the company had previously offered change sections to adjust their prevailing equipment, that is now developed apparatus particularly planned to employ paper-based grips at measures. Collectively, the multipack option and the devoted equipment establish a completely combined packaging option.
Aditi serves as Vice President at Towards Packaging, bringing over 15 years of experience in market research, innovation, and business strategy within the packaging industry. She works across segments such as sustainable packaging, flexible materials, and industrial packaging solutions. Aditi studies evolving consumer demands, material advancements, and regulatory changes, then turns those insights into clear strategies for businesses. She helps organizations stay competitive, improve product positioning, and respond effectively to shifting market trends.
Aman Singh has spent more than 13 years working in research and consulting, with a strong focus on the global packaging sector. He tracks developments in areas like eco-friendly materials, smart packaging technologies, and supply chain changes. At Towards Packaging, Aman leads the research team and ensures every study delivers accurate and useful insights. He breaks down complex industry developments and helps companies understand where opportunities lie and how to act on them.
Piyush Pawar works as Senior Manager for Sales and Business Growth at Towards Packaging, bringing over a decade of experience in client-facing roles within the packaging industry. He connects businesses with the right research and helps them apply insights to real-world decisions. Piyush understands market challenges and works closely with clients to provide solutions that support growth. He focuses on building strong partnerships and helping companies turn industry knowledge into practical results.
Smurfit WestRock Horizon Facility Strengthens Clinical Packaging Market
Request Consultation
